2026 data ClinicalTrials.gov official source

Conditions: R

Every condition beginning with R that has a registered US clinical trial, with how many studies cover each.

1,694 conditions starting with "R"

Showing 701–750 of 1,694

Condition Trials
Recurrent, CNS Tumor, Childhood 1
Recurrent, Refractory, or High Risk Leukemias 1
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) 1
Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC) 1
Recurrent/Refractory Secondary Central Nervous System Lymphoma 1
Red Blood Cell Survival 1
Red Blood Cell Transfusion 1
Red Cell Membrane and Enzyme Abnormalities 1
Red Tide 2
Red-Cell Aplasia, Pure 1
Reduced Pain Response 1
Reduced Physical Activity 1
Reduced Ventricular Ejection Fraction 1
Reducing Excess Blood Transfusion 1
Reducing Pain With Nexplanon Implant Insertion 1
Reducing Time to Vaginal Delivery 1
Reduction in Severity of Skin Scarring 1
Reduction of Substance Use-related Stigma 1
Reduction, Weight 1
Referred Pain 1
Reflex Syncope 1
Reflux 3
Reflux Esophagitis 1
Reflux, Gastroesophageal 1
Refractive Ametropia 6
Refractive Error 6
Refractive Error - Myopia 1
Refractive Error - Myopia Severe 1
Refractive Error - Myopia Simple 1
Refractive Errors 15
Refractive Lens Exchange 1
Refractive Surgery 3
Refractory 5
Refractory Acute Biphenotypic Leukemia 2
Refractory Acute Leukemia 4
Refractory Acute Leukemia of Ambiguous Lineage 3
Refractory Acute Lymphoblastic Leukemia 22
Refractory Acute Lymphoblastic Leukemia (ALL) 2
Refractory Acute Lymphoid Leukemia in Relapse 1
Refractory Acute Myelogenous Leukemia (AML) 1
Refractory Acute Myeloid Leukemia 64
Refractory Acute Myeloid Leukemia (AML) 2
Refractory Acute Myeloid Leukemia Due to Lineage Switch From Acute Leukemia of Ambiguous Lineage 1
Refractory Acute Myeloid Leukemia Due to Lineage Switch From B Acute Lymphoblastic Leukemia, KMT2A-Rearranged 1
Refractory Acute Undifferentiated Leukemia 2
Refractory Adult Acute Lymphoblastic Leukemia 2
Refractory Adult T-Cell Leukemia/Lymphoma 1
Refractory Aggressive B-cell Lymphomas 1
Refractory Aggressive Non-Hodgkin Lymphoma 1
Refractory AL Amyloidosis 3

Related

Data sourced from official public datasets. See our methodology for details.